Text message therapy for mood and behavior symptoms in mild cognitive impairment
Tests text message therapy for people with mild cognitive impairment.
Key facts
- Who runs it
- The University of Hong Kong
- Where
- Hong Kong1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Instant Message-delivered Personalised Acceptance and Commitment Therapy (ACT) for Neuropsychiatric Symptoms in Persons With Mild Cognitive Impairment
- Status
- Enrolling by invitation
- People taking part
- 40 people, planned
- Started
- 17 Sept 2025
- Planned end
- Mar 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Automated instant message-guided neuropsychiatric symptoms management
- Record updated
- 12 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 50 or older with mild memory and thinking problems (mild cognitive impairment) who live at home and have mood or behaviour symptoms. It tests a therapy delivered by smartphone messages.
- Age
- 50 years and older
- Sex
- All sexes
- Disease stage
- Mild cognitive impairment with an HK-MoCA score from 18 to 25 and an MBI-C score of 7 or more (MBI-C measures mood and behaviour changes).
- Earlier treatment
- People cannot join if they are now taking part in any psychological or behavioural program for mood or behaviour symptoms.
Main reasons for not taking part
- Diagnosis of dementia
- Diagnosis of a psychiatric disease
- Now in a psychological or behavioural program for mood or behaviour symptoms
- Not able to read and communicate in Chinese (Cantonese or Putonghua)
- Not able to use text or voice messages on a smartphone
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Community-dwelling adults aged ≥ 50 years; HK-MoCA score range from 18 to 25; MBI-C ≥7; Able to read and communicate in Chinese (Cantonese or Putonghua); Able to use the text or voice messaging function on a smartphone
Who cannot take part
- Diagnosis of dementia; Diagnosis of psychiatric disease; Currently participating in any type of psychological or behavioural intervention for NPSs
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This pilot study aims to develop an automated instant message-delivered intervention (i.e., EMI) for people with mild cognitive impairment, and to investigate the feasibility and effectiveness of the intervention.
The 2 groups in the trial
- Intervention groupTreatment being tested
Participants in intervention group will receive the EMI for 8 weeks. Based on the steps of mobile message development recommended by Abroms, et al., our team will develop an ACT message content library and protocol for IM delivery (i.e. EMI).
Treatment: Automated instant message-guided neuropsychiatric symptoms management
- Control groupNo study treatment, for comparison
The control group will receive instant messages about general mental health management from the HKSAR Government website, which is open to the public (https://www.shallwetalk.hk/en/mental-well-being/mental-well-being-is-related-to-you/), with reminder text messages of follow-up surveys.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Instant Message-delivered Acceptance and Commitment Therapy (ACT) for Neuropsychiatric Symptoms in Persons Living With Mild Cognitive Impairment: a Pilot Randomised Controlled Trial
- Plain-language title
- Text message therapy for mood and behavior symptoms in mild cognitive impairmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 12 January 2026